Delivery Order SPE2DB22D3301-SPE2DB24FZ2HU

Award Date 8/7/24
Potential Completion Date 8/28/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a Firm Fixed Price Delivery Order contract worth $3,999.18 for the supply of PROMACTA 12.5 MG TABLET UU 30S. This contract has an ultimate completion date of May 21, 2024 and is not set aside for any specific business category. Amerisourcebergen Drug Corp's Corporate Office Division, which manages the company's federal government contracts, will fulfill this order....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a leading pharmaceutical distributor. The $7,242.58 firm-fixed-price contract is for the supply of PROMACTA 50 MG TABLET, a specialty medication. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds several key Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, enabling the efficient...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,026.53, is for the delivery of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of March 12, 2025 and is a firm fixed-price delivery order. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.89 Firm Fixed Price delivery order is for the drug Promacta 50 mg tablets, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the drug Promacta 50 mg tablets, with a ceiling value of $7,242.58 and an ultimate completion date of October 8, 2024. The contract is a Firm Fixed Price agreement, with no set-aside designation noted. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,492.89, is for the delivery of PROMACTA 50 MG TABLET medical products. This is a firm fixed-price delivery order contract with an ultimate completion date of December 13, 2024. The contract was awarded on November 21, 2024 and does not have a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $21,727.74 firm fixed-price contract is for the supply of PROMACTA 50 MG TABLET medical products. It is not a set-aside contract. The delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $7,242.58, is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The order is a firm fixed-price contract and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical and medical products to various government agencies, including the DLA, which is a large defense agency that supports...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,836.12 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,455 units of the medication Promacta 25 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $3,997.21 and an ultimate completion date of September 5, 2024. This contract is not designated as a set-aside. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous Indefinite Delivery...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2HU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $3,997.21, is for the supply of Promacta 25 mg tablets. The order is a firm-fixed price contract with an ultimate completion date of August 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply a wide range of medications and medical supplies to military treatment facilities, veterans' hospitals, and other government healthcare providers. The company holds large Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of critical medical commodities. This specific delivery order does not have a set-aside designation.

Generated 11/6/24, 9:22 AM